Rule 144 Definition Example

Registration Rights Agreement, dated January 30, 2024, by and between cbdMD, Inc. and the Investor (Filed With SEC on February 2, 2024)

EXCHANGE AGREEMENT (Filed With SEC on January 12, 2007)

(Filed With SEC on November 17, 2006)

STOCK PURCHASE AGREEMENT (Filed With SEC on April 30, 2010)

STOCK PURCHASE AGREEMENT (Filed With SEC on November 24, 2006)

EXCHANGE AGREEMENT (Filed With SEC on February 28, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 22, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 4, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 4, 2008)

Securities Purchase Agreement, dated as of April 5, 2024 between Biodesix, Inc. and certain of the Investors (Filed With SEC on April 9, 2024)

Securities Purchase Agreement, dated as of April 5, 2024 between Biodesix, Inc. and certain members of management, certain of its directors and funds affiliated with those... (Filed With SEC on April 9, 2024)

Form of Securities Purchase Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the purchasers as party thereto (Filed With SEC on April 9, 2024)

Form of Securities Purchase Agreement (Filed With SEC on July 30, 2024)

Form of Securities Purchase Agreement, dated August 6, 2024, by and among Tenax Therapeutics, Inc. and the investors signatory thereto (Filed With SEC on August 6, 2024)

Form of Securities Purchase Agreement, dated March 4, 2025, by and among Tenax Therapeutics, Inc. and the investors signatory thereto (Filed With SEC on March 6, 2025)

Form of Securities Purchase Agreement (Filed With SEC on September 12, 2024)

Form of Securities Purchase Agreement (Filed With SEC on October 22, 2025)

Securities Purchase Agreement, dated as of October 9, 2024 (Filed With SEC on October 10, 2024)

Subscription Agreement, dated December 19, 2024, and each purchaser identified on Exhibit A thereto (Filed With SEC on December 20, 2024)

Form of Securities Purchase Agreement (Filed With SEC on December 27, 2024)

Form of Securities Purchase Agreement, dated June 25, 2025, by and between the Company and Yantai Rongpu Investment Partnership (Limited Partnership) (Filed With SEC on June 26, 2025)

Form of Securities Purchase Agreement, dated June 25, 2025, by and between the Company and the investors named therein (Filed With SEC on June 26, 2025)

Form of Securities Purchase Agreement, dated as of January 3, 2025 between Outset Medical, Inc. and certain of the Investors (Filed With SEC on January 6, 2025)

Form of Securities Purchase Agreement, dated as of January 3, 2025 between Outset Medical, Inc. and certain members of management and certain directors (Filed With SEC on January 6, 2025)

Securities Purchase Agreement, dated February 11, 2025, by and among the Company and the Purchasers (Filed With SEC on February 12, 2025)

Securities Purchase Agreement, dated March 24, 2025, by and among the Company and the Purchasers (Filed With SEC on March 25, 2025)

(Filed With SEC on May 11, 2005)

(Filed With SEC on January 22, 2007)

(Filed With SEC on January 9, 2004)

(Filed With SEC on September 30, 2005)

Form of Securities Purchase Agreement (Filed With SEC on June 6, 2025)

Form of Securities Purchase Agreement, dated June 12, 2025, by and among Quince Therapeutics, Inc. and each of the several purchasers signatory thereto (Filed With SEC on June 13, 2025)

Form of Securities Purchase Agreement, dated June 25, 2025, by and among Actuate Therapeutics, Inc. and each of the purchasers party thereto (Filed With SEC on June 26, 2025)

Securities Purchase Agreement, dated August 10, 2025, by and among the Company and the Investors (Filed With SEC on August 11, 2025)

Form of Securities Purchase Agreement dated September 2, 2025, by and among the Company and the investors party thereto (Filed With SEC on September 2, 2025)

Securities Purchase Agreement dated September 5, 2025 (Filed With SEC on September 8, 2025)

Form of Securities Purchase Agreement (Filed With SEC on September 11, 2025)

Securities Purchase Agreement, dated as of October 2, 2025, by and among Ovid Therapeutics Inc. and the Investors named therein (Filed With SEC on October 3, 2025)

Securities Purchase Agreement, dated October 6, 2025, by and among Jade Biosciences, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on October 7, 2025)

Form of Securities Purchase Agreement, dated October 16, 2025, by and between the Company and the Purchaser (Filed With SEC on October 17, 2025)

Form of Securities Purchase Agreement, dated as of November 10, 2025, by and among Galecto, Inc. and each investor listed on Exhibit A thereto (Filed With SEC on November 10, 2025)